{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:49:39Z","timestamp":1757591379760},"reference-count":29,"publisher":"Royal College of Psychiatrists","issue":"4","license":[{"start":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T00:00:00Z","timestamp":1517184000000},"content-version":"unspecified","delay-in-days":13634,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Psychiatry"],"published-print":{"date-parts":[[1980,10]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Concentrations of noradrenaline (NA), homovanillic acid, 5-hydroxyindoleacetic acid and cyclic nucleotides were determined in lumbar cerebrospinal fluid (CSF) from acute and chronic schizophrenics and various groups of psychiatric and non-psychiatric control subjects. Statistically significant increases in NA and cyclic adenosine monophosphate were found in CSF from chronic schizophrenics compared to all other groups. These results were shown by statistical analyses to be unrelated to medication. They may be interpreted as evidence for noradrenergic overactivity as a possible primary abnormality in chronic schizophrenia.<\/jats:p>","DOI":"10.1192\/bjp.137.4.346","type":"journal-article","created":{"date-parts":[[2008,8,12]],"date-time":"2008-08-12T18:35:43Z","timestamp":1218566143000},"page":"346-351","source":"Crossref","is-referenced-by-count":71,"title":["Noradrenergic Overactivity in Chronic Schizophrenia: Evidence Based on Cerebrospinal Fluid Noradrenaline and Cyclic Nucleotide Concentrations"],"prefix":"10.1192","volume":"137","author":[{"given":"U. C. R.","family":"Gomes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. C.","family":"Shanley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Potgieter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. T.","family":"Roux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"170","published-online":{"date-parts":[[2018,1,29]]},"reference":[{"key":"S0007125000071853_ref11","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(77)90214-1"},{"key":"S0007125000071853_ref5","doi-asserted-by":"publisher","DOI":"10.1017\/S003329170000622X"},{"key":"S0007125000071853_ref12","volume-title":"Psychopharmacology: a generation of progress","author":"Friedhoff","year":"1978"},{"key":"S0007125000071853_ref20","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(77)90070-4"},{"key":"S0007125000071853_ref28","article-title":"Relationship between norepinephrine in blood and cerebrospinal fluid in the presence of a blood-cerebrospinal fluid barrier for norepinephrine","volume":"28","author":"Ziegler","year":"1977","journal-title":"Journal of Neurochemistry"},{"key":"S0007125000071853_ref10","doi-asserted-by":"publisher","DOI":"10.1126\/science.644310"},{"key":"S0007125000071853_ref1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1979.01780090013001"},{"key":"S0007125000071853_ref27","volume-title":"Foundations of Biochemical Psychiatry","author":"Wyatt","year":"1976"},{"key":"S0007125000071853_ref4","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1974.01760130034005"},{"key":"S0007125000071853_ref18","doi-asserted-by":"publisher","DOI":"10.1038\/274897a0"},{"key":"S0007125000071853_ref9","doi-asserted-by":"publisher","DOI":"10.1080\/00401706.1964.10490181"},{"key":"S0007125000071853_ref3","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(76)90043-1"},{"key":"S0007125000071853_ref22","article-title":"Cerebrospinal fluid norepinephrine in affective illness","volume":"135","author":"Post","year":"1978","journal-title":"American Journal of Psychiatry"},{"key":"S0007125000071853_ref2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.130.1.64"},{"key":"S0007125000071853_ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1973.tb04225.x"},{"key":"S0007125000071853_ref7","first-page":"1","article-title":"Evidence for the existence of monoamine neurons in the central nervous system. II. Experimentally induced changes in the intraneuronal amine levels of bulbospinal neurons systems","volume":"64","author":"Dahlstrom","year":"1965","journal-title":"Acta Physiologica Scandinavica"},{"key":"S0007125000071853_ref8","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.38.2.109"},{"key":"S0007125000071853_ref17","doi-asserted-by":"publisher","DOI":"10.1126\/science.7350667"},{"key":"S0007125000071853_ref13","volume-title":"Interactions between putative neurotransmitters","author":"Garattini","year":"1978"},{"key":"S0007125000071853_ref26","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.39.12.1186"},{"key":"S0007125000071853_ref15","article-title":"Fluprometric determination of homovanillic acid in tissues using anion exchange separation and mixed solvent elution","volume":"25","author":"Korf","year":"1971","journal-title":"Acta Chimica Scandinavica"},{"key":"S0007125000071853_ref16","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(69)90383-0"},{"key":"S0007125000071853_ref19","volume-title":"Catecholamines and Schizophrenia","author":"Matthyse","year":"1975"},{"key":"S0007125000071853_ref21","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1975.01760260127011"},{"key":"S0007125000071853_ref23","volume-title":"Schizophrenia Today","author":"Richter","year":"1976"},{"key":"S0007125000071853_ref24","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(76)90383-0"},{"key":"S0007125000071853_ref25","volume-title":"New Perspectives in Schizophrenia","author":"Smythies","year":"1975"},{"key":"S0007125000071853_ref29","article-title":"Clinical correlates of CSF cyclic nucleotides in schizophrenia","volume":"135","author":"Zohar","year":"1978","journal-title":"American Journal of Psychiatry"},{"key":"S0007125000071853_ref14","volume-title":"Biochemistry of Mental Disorders\u2014New Vistas","author":"Goodwin","year":"1978"}],"container-title":["British Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0007125000071853","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T17:31:03Z","timestamp":1558805463000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0007125000071853\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1980,10]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1980,10]]}},"alternative-id":["S0007125000071853"],"URL":"https:\/\/doi.org\/10.1192\/bjp.137.4.346","relation":{},"ISSN":["0007-1250","1472-1465"],"issn-type":[{"value":"0007-1250","type":"print"},{"value":"1472-1465","type":"electronic"}],"subject":[],"published":{"date-parts":[[1980,10]]}}}